Facebook
Twitter
LinkedIn
Forward
This presentation discusses the particular administrative needs and challenges related to treating obesity.
|
Selecting the correct on label or off label medication to treat obesity can be confusing. The acronym RXAOM provides a framework for individualizing the selection process.
|
In June of 2023 the AASLD updated the nomenclature for NAFLD to Metabolic dysfunction-Associated Steatotic Liver Disease(MASLD).
|
Printed Syllabus including lecture slides and case work
|
Printed Syllabus including lecture slides and case work
|
Obesity is a chronic, serious life threatening disease, but treatments exist. Obesity is associated with an increased risk of CVD and CV-associated mortality.
|
Obesity is one of the leading causes of preventable death. Obesity-related increases metabolic and cardiovascular risk occur at a lower body mass index in Asian adults.
|
This session utilizes a direct instructional format to expand on the recent American Academy of Pediatrics Clinical Practice Guidelines for the Evaluation and Treatment of Children and Adolescents
|
Fundamentals of Obesity Treatment - On Demand is a course offering introductory education about the evidence-based approaches for evaluating, diagnosing, and treating obesity in a clinical setti
|
Join Dr. Angela Fitch for this Obesity Care Week webinar to dissect and raise awareness of the complexities of obesity from a medical perspective.
|